BioSpace News Archive

NanoView Biosciences, Inc. and Izasa Scientific announced an exclusive distribution agreement for NanoView’s ExoView® platform in Spain and Portugal.

The U.S. Food and Drug Administration is issuing a Safety Communication to inform patients and health care providers that devices claiming to clean, disinfect or sanitize continuous positive airway pressure devices or accessories using ozone gas or ultraviolet light are not legally marketed for this use by the FDA in the U.S., and as such, their safety and effectiveness for use with CPAP devices and accessories is unknown.

America’s emergency care teams—which serve on the frontlines of any pandemic response—have urged Congress to approve emergency supplemental appropriations to ensure our health system has the resources necessary to address an outbreak of the novel coronavirus in the U.S.

As I have previously communicated, the FDA has been closely monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or shortages of critical medical products in the U.S.

CVS Health Corporation announced that Eva Boratto, Executive Vice President and Chief Financial Officer, and Alan Lotvin, Executive Vice President and President of CVS Caremark, will be participating in a fireside chat with investors at the Barclays Global Healthcare Conference on March 12, 2020, at approximately 8:30 a.m. ET.

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced that Bill Newell, Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Wednesday,

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will present at the following upcoming investor conferences

CANTEL MEDICAL CORP. (NYSE: CMD) announced today that in line with its focus on key growth opportunities, Seth Yellin has been promoted to the newly created role of Executive Vice President and Chief Growth Officer

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate in the Cowen 40th Annual Healthcare Conference in Boston.

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, announced 510(k) clearance from the U.S. Food and Drug Administration for a new generation of its Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, known as PSDV with Secure Grip